Supported in part by grant No. HD04612 to the Mental Retardation Research Center. Presented at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 1118, 1992.

This publication has 9 references indexed in Scilit:

• First‐trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders
  Prenatal Diagnosis, 1992
• Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and age
  Prenatal Diagnosis, 1991
• First‐trimester maternal serum biochemical indicators in Down syndrome
  Prenatal Diagnosis, 1990
• Maternal serum markers in screening for Down syndrome
  Clinical Genetics, 1990
• Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses
  Prenatal Diagnosis, 1989
• FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME
  The Lancet, 1988
• Maternal serum screening for Down's syndrome in early pregnancy.
  BMJ, 1988
• Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities
  Prenatal Diagnosis, 1987
• Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.
  Clinical Chemistry, 1983